NYSEARCA:NNVC • US6300873022
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NANOVIRICIDES INC (NNVC).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-05-07 | EF Hutton | Reiterate | Buy -> Buy |
| 2024-02-16 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-04-18 | EF Hutton | Reiterate | Buy |
| 2023-02-28 | EF Hutton | Maintains | Buy |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A -91.93% | ||||||||||
| EBITDA YoY % growth | -6.76M | -8.2M -21.30% | -8.94M -9.02% | -8.64M 3.36% | -7.96M 7.87% | -7.3M 8.29% | -8.03M -10.00% | -7.38M 8.09% | -8.19M -10.98% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.06M | -8.86M -25.50% | -9.6M -8.35% | -9.32M 2.92% | -8.66M 7.08% | -8M 7.62% | -8.74M -9.25% | -8.11M 7.21% | -8.94M -10.23% | N/A 6.72% | N/A -27.87% | N/A 18.39% | N/A -12.52% | N/A -8.59% | N/A 5,308.63% | N/A 9.58% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -0.71 53.59% | N/A 13.80% | -0.70 -14.38% | N/A 16.94% | N/A 17.54% | N/A 2.13% | N/A 6.52% | N/A | N/A |
All data in USD
| Q3 / 26 | Q4 / 26 | |
|---|---|---|
| EPS Q2Q % growth | -0.13 | -0.19 |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -2.219M 1.36% | -2.321M -9.69% |
All data in USD
7 analysts have analysed NNVC and the average price target is 6.46 USD. This implies a price increase of 580% is expected in the next year compared to the current price of 0.95.
NANOVIRICIDES INC (NNVC) will report earnings on 2026-05-13.
The consensus EPS estimate for the next earnings of NANOVIRICIDES INC (NNVC) is -0.13 USD and the consensus revenue estimate is 0 USD.